# Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

> **NCT00041249** · PHASE2 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 64 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumor
- Sarcoma

## Interventions

- **DRUG:** brostallicin

## Key facts

- **NCT ID:** NCT00041249
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2004-01
- **Final completion:** —
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2012-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041249, "Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00041249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*